Resmed Inc. buy UBS Group AG
Start price
24.04.25
/
50%
€207.50
Target price
24.04.26
€251.00
Performance (%)
0.48%
Price
30.12.25
€208.50
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Resmed Inc. is nearly unchanged. This prediction currently runs until 24.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.530% | 0.530% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at UBS Group AG from $290.00 to $285.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat